Jaguar health appoints karen brunke, ph.d. as corporate and business development evp and chip whitlow as animal health products marketing director

Appointments represent jaguar's focus on forging business development partnerships to advance crofelemer development and access and preparing for the expected near-term approval and commercialization of crofelemer prescription product for chemotherapy-induced diarrhea in dogs company to host investor webcast monday, september 20th at 8:30 a.m. eastern; click here to register for webcast san francisco, ca / accesswire / september 9, 2021 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced the appointment of karen j.
JAGX Ratings Summary
JAGX Quant Ranking